This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Joanne Hulme, Ph.D.
Chief Scientific Officer at Radiant Biotherapeutics


Dr. Joanne Hulme currently serves as Chief Scientific Officer of Radiant Biotherapeutics, an innovative antibody platform company developing multi-valent and multi-specific biotherapeutics with broad transformative applications. Prior to Radiant Biotherapeutics, she was VP, Head of Research for Northern Biologics, where she developed first-in-class antibody therapeutics in cancer and fibrotic diseases. Prior to Northern, Dr. Hulme previously worked at Amgen, where her research resulted in the development of multiple preclinical programs in autoimmune diseases and cancer. Dr. Hulme earned her Ph.D. in Pharmacology from the University of Leeds.

Agenda Sessions

  • Multabodies: Exploiting Avidity and Multi-specificity to Achieve Ultra-potent Biologics